The value of 7 peripheral blood serum ratios in diagnosis and prediction of disease activity of patients within inflammatory bowel disease individuals
Authors:
Open Access
- 5 April 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10
Abstract
Objective: In recent years, a number of studies have suggested that inflammation-based biomarkers can be applied in the diagnostics and prognostic testing of disease. However, the association between these ratios and inflammatory bowel disease (IBD) remains unclear. We aimed to investigate the role of these inflammation-based ratios in patients with IBD.Methods: Retrospective analysis of 362 patients with IBD and 100 healthy individuals from January 2016 and December 2021. The receiver operating characteristic curve and logistic regression analysis was applied to explore the diagnostic and predictive performance of the seven ratio markers [neutrophil- to-albumin ratio (NAR), neutrophil-to-pre-albumin ratio (NPAR), albumin-to-alkaline-phosphatase ratio (AAPR), albumin-to-globulin ratio (AGR), albumin-to-fibrinogen ratio (AFR), fibrinogen-to-pre-albumin ratio (FPR), and Prognostic Nutritional Index (PNI)] regarding to disease activity in IBD individuals.Results: Compared with healthy controls, patients with Crohn’s disease (CD) or ulcerative colitis (UC) exhibited higher levels of NAR, NPAR, FPR (P < 0.001), lower levels of AAPR, and PNI (P < 0.001). Multivariate logistic regression showed that the level of NPAR (OR = 1.12, 95%CI: 1.02–1.23, P = 0.016) and AGR (OR = 1.01, 95%CI: 1.01–1.12, P < 0.001) was an independent risk factor of IBD. Then, we found the level of NPAR (OR = 1.10, 95%CI: 1.01–1.20, P = 0.02) and PNI (OR = 0.83, 95%CI: 0.71–0.96, P = 0.01) was independently associated with disease activity. Besides, a positive association was observed between the level of NPAR and two clinical scores [Harvey Bradshaw index (HBI) in patients with CD, Mayo score in patients with UC]. Finally, the level of NPAR (P = 0.002) and PNI (P = 0.003) showed a significant difference in the IBD-associated neoplasia group and IBD without neoplasia group.Conclusion: Our data first suggests NPAR as a putative biomarker for diagnosing and predicting disease activity in patients with IBD. Investigations involving a larger number of IBD individuals are necessary to validate its use as an easily obtained peripheral blood biomarker of IBD.Keywords
This publication has 43 references indexed in Scilit:
- Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative ColitisClinical Gastroenterology and Hepatology, 2015
- Biomarkers of Inflammation in Inflammatory Bowel DiseaseGastroenterology, 2015
- The global burden of IBD: from 2015 to 2025Nature Reviews Gastroenterology & Hepatology, 2015
- Effects of preoperative and postoperative enteral nutrition on postoperative nutritional status and immune function of gastric cancer patientsTurkish Journal of Gastroenterology, 2015
- Incidence, Management, and Course of Cancer in Patients with Inflammatory Bowel DiseaseJournal of Crohn's and Colitis, 2015
- Random Biopsies Taken During Colonoscopic Surveillance of Patients With Longstanding Ulcerative Colitis: Low Yield and Absence of Clinical ConsequencesAmerican Journal of Gastroenterology, 2014
- Performance of the Montreal classification for inflammatory bowel diseasesWorld Journal of Gastroenterology, 2014
- Catalytic intermolecular β-C–H alkenylation of α-enamino-ketones with simple alkynesChemical Communications, 2013
- Novel Methylation Panel for the Early Detection of Neoplasia in High-risk Ulcerative Colitis and Crohnʼs Colitis PatientsInflammatory Bowel Diseases, 2013
- Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case–control studyCellular Oncology, 2011